CSL Behring UK Ltd
Supplier — contracts won
£2.9bnTotal value£2,912,135,565 across every award on file
5Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 3 | £2.9bn |
| Norfolk and Norwich University Hospitals NHS… | 1 | £416k |
| The Christie NHS Foundation Trust | 1 | £12k |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
| 1 Jan 2025 | CSL Behring - Blood Disorder Treatment products (inc Haemophilia A & B)East of England | Norfolk and Norwich University Hospitals NHS… | CSL BEHRING UK LIMITED | £416k |
| 12 Jun 2026 | Beriplex | The Christie NHS Foundation Trust | CSL BEHRING UK LIMITED | £12k |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.